Definition Of 'Patient-Centered Outcomes Research' Is Finalized, Despite Some Grumbling
This article was originally published in The Gray Sheet
Executive Summary
The need to move forward outweighs some members’ objections to the final definition developed by the Patient-Centered Outcomes Research Institute’s Methodology Committee.
You may also be interested in...
PCORI Seeks Public Input On Definition Of "Patient-Centered Outcomes Research"
Outreach efforts include web-based survey as the public/private Patient-Centered Outcomes Research Institute looks to finish a key part of its foundation and move forward on research activities.
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.